Literature DB >> 16939624

Structural and biochemical characterization of a human adenovirus 2/12 penton base chimera.

Chloe Zubieta1, Laurent Blanchoin, Stephen Cusack.   

Abstract

The vertex of the adenoviral capsid is formed by the penton, a complex of two proteins, the pentameric penton base and the trimeric fiber protein. The penton contains all necessary components for viral attachment and entry into the host cell. After initial attachment via the head domain of the fiber protein, the penton base interacts with cellular integrins through an Arg-Gly-Asp (RGD) motif located in a hypervariable surface loop, triggering virus internalization. In order to investigate the structural and functional role of this region, we replaced the hypervariable loop of serotype 2 with the corresponding, but much shorter, loop of serotype 12 and compared it to the wild type. Here, we report the 3.6 A crystal structure of a human adenovirus 2/12 penton base chimera crystallized as a dodecamer. The structure is generally similar to human adenovirus 2 penton base, with the main differences localized to the fiber protein-binding site. Fluorescence anisotropy assays using a trimeric fiber protein mimetic called the minifiber and wild-type human adenovirus 2 and chimeric penton base demonstrate that fiber protein binding is independent of the hypervariable loop, with a K(d) for fiber binding estimated in the 1-2 microm range. Interestingly, competition assays using labeled and unlabeled minifiber demonstrated virtually irreversible binding to the penton base, which we ascribe to a conformational change, on the basis of comparisons of all available penton base structures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16939624     DOI: 10.1111/j.1742-4658.2006.05430.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  8 in total

1.  Structure of Sputnik, a virophage, at 3.5-Å resolution.

Authors:  Xinzheng Zhang; Siyang Sun; Ye Xiang; Jimson Wong; Thomas Klose; Didier Raoult; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

Review 2.  Adenovirus.

Authors:  Jason G Smith; Christopher M Wiethoff; Phoebe L Stewart; Glen R Nemerow
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Mechanisms of human adenovirus inactivation by sunlight and UVC light as examined by quantitative PCR and quantitative proteomics.

Authors:  Franziska Bosshard; Florence Armand; Romain Hamelin; Tamar Kohn
Journal:  Appl Environ Microbiol       Date:  2012-12-14       Impact factor: 4.792

4.  Selection Pressure in the Human Adenovirus Fiber Knob Drives Cell Specificity in Epidemic Keratoconjunctivitis.

Authors:  Ashrafali M Ismail; Ji Sun Lee; David W Dyer; Donald Seto; Jaya Rajaiya; James Chodosh
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

Review 5.  Latest insights on adenovirus structure and assembly.

Authors:  Carmen San Martín
Journal:  Viruses       Date:  2012-05-21       Impact factor: 5.048

6.  Protein crystals in Adenovirus type 5-infected cells: requirements for intranuclear crystallogenesis, structural and functional analysis.

Authors:  Laure Franqueville; Petra Henning; Maria Magnusson; Emmanuelle Vigne; Guy Schoehn; Maria E Blair-Zajdel; Nagy Habib; Leif Lindholm; G Eric Blair; Saw See Hong; Pierre Boulanger
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

7.  Genomic Analyses of Potential Novel Recombinant Human Adenovirus C in Brazil.

Authors:  Roozbeh Tahmasebi; Antonio Charlys da Costa; Kaelan Tardy; Rory J Tinker; Flavio Augusto de Padua Milagres; Rafael Brustulin; Maria da Aparecida Rodrigues Teles; Rogério Togisaki das Chagas; Cassia Vitória de Deus Alves Soares; Aripuana Sakurada Aranha Watanabe; Cecilia Salete Alencar; Fabiola Villanova; Xutao Deng; Eric Delwart; Adriana Luchs; Élcio Leal; Ester Cerdeira Sabino
Journal:  Viruses       Date:  2020-05-04       Impact factor: 5.048

Review 8.  Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic.

Authors:  Samir Andrade Mendonça; Reka Lorincz; Paul Boucher; David T Curiel
Journal:  NPJ Vaccines       Date:  2021-08-05       Impact factor: 7.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.